We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.6M |
| 2 |
Autodesk
ADSK
|
+$38.8M |
| 3 |
Intuit
INTU
|
+$37.1M |
| 4 |
Ecolab
ECL
|
+$35.6M |
| 5 |
Coca-Cola
KO
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
EOG Resources
EOG
|
+$33.8M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$32M |
| 4 |
Microsoft
MSFT
|
+$29.8M |
| 5 |
Ford
F
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.53% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Dycom Industries
DY
$12.9B
| $2.28M | 0.03% |
38,680
+12,320
| +47% | +$631K |
|
|
ACIA
502
DELISTED
Acacia Communications Inc
ACIA
| $2.26M | 0.03% |
47,867
+4,800
| +11% | +$252K |
|
|
ASRT
503
DELISTED
Assertio
ASRT
| $2.23M | 0.03% |
10,774
-440
| -4% | -$105K |
|
|
MRO
504
DELISTED
Marathon Oil Corporation
MRO
| $2.21M | 0.03% |
155,701
+121,600
| +357% | +$1.88M |
|
505
LivePerson
LPSN
$18.9M
| $2.13M | 0.03% |
5,062
-3,542
| -41% | -$1.51M |
|
|
NXRT
506
NexPoint Residential Trust
NXRT
$665M
| $2.13M | 0.03% |
51,333
-76,214
| -60% | -$2.98M |
|
507
Scholastic
SCHL
$796M
| $2.13M | 0.03% |
63,916
+7,560
| +13% | +$282K |
|
|
XHR
508
Xenia Hotels & Resorts
XHR
$1.98B
| $2.11M | 0.03% |
101,254
+49,720
| +96% | +$1.07M |
|
509
Union Pacific
UNP
$183B
| $2.09M | 0.03% |
+12,370
| New | +$2.12M |
|
510
Four Corners Property Trust
FCPT
$2.86B
| $2.08M | 0.03% |
75,928
+2,120
| +3% | +$60.6K |
|
511
Comscore
SCOR
| $2.07M | 0.03% |
20,085
+16,690
| +492% | +$3.57M |
|
512
Groupon
GRPN
$980M
| $2.07M | 0.03% |
28,923
+10,124
| +54% | +$714K |
|
|
TCF
513
DELISTED
TCF Financial Corporation
TCF
| $2.06M | 0.03% |
99,200
-33,400
| -25% | -$697K |
|
|
PRSU
514
Pursuit Attractions and Hospitality Inc
PRSU
$1.43B
| $2.06M | 0.03% |
31,067
-5,830
| -16% | -$360K |
|
515
QCR Holdings
QCRH
$1.65B
| $2.06M | 0.03% |
59,003
+8,770
| +17% | +$298K |
|
516
SL Green Realty
SLG
$3.88B
| $2.04M | 0.03% |
26,163
-568
| -2% | -$47.9K |
|
517
Skyworks Solutions
SWKS
$9.06B
| $2.02M | 0.03% |
+26,200
| New | +$2.08M |
|
|
DRE
518
DELISTED
Duke Realty Corp.
DRE
| $2.02M | 0.03% |
64,040
-9,440
| -13% | -$292K |
|
519
Westlake Corp
WLK
$9.46B
| $2.02M | 0.03% |
29,130
-16,220
| -36% | -$1.08M |
|
|
EXTN
520
DELISTED
Exterran Corporation
EXTN
| $2.02M | 0.03% |
142,076
+23,260
| +20% | +$341K |
|
|
LCI
521
DELISTED
Lannett Company, Inc.
LCI
| $2.01M | 0.03% |
82,977
+36,225
| +77% | +$957K |
|
522
Inspire Medical Systems
INSP
$1.42B
| $2.01M | 0.03% |
33,100
+13,900
| +72% | +$749K |
|
|
SPTN
523
DELISTED
SpartanNash
SPTN
| $2.01M | 0.03% |
171,964
+118,564
| +222% | +$1.69M |
|
|
QADA
524
DELISTED
QAD Inc.
QADA
| $1.98M | 0.03% |
49,307
+3,940
| +9% | +$176K |
|
|
PFC
525
DELISTED
Premier Financial Corp. Common Stock
PFC
| $1.98M | 0.03% |
69,340
+11,500
| +20% | +$329K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2019 Portfolio in Review
As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
- Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
- Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
- Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
- Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
- Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.